Stay updated on Pembrolizumab and CMP-001 in Operable Melanoma Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab and CMP-001 in Operable Melanoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab and CMP-001 in Operable Melanoma Clinical Trial page

  1. Check
    yesterday
    Change Detected
    Summary
    The page’s interface revision indicator was updated from v3.5.2 to v3.5.3, reflecting a minor website/version update rather than a change to the clinical trial information.
    Difference
    0.0%
    Check dated 2026-04-25T05:32:45.000Z thumbnail image
  2. Check
    8 days ago
    Change Detected
    Summary
    Added a new 'Study Status' entry to the version history and updated the page revision from v3.5.0 to v3.5.2.
    Difference
    0.1%
    Check dated 2026-04-18T03:51:06.000Z thumbnail image
  3. Check
    16 days ago
    Change Detected
    Summary
    New history entries 204–207 (dated 2026-04-04 to 2026-04-09) appear; the log now includes a Study Status entry in the changes.
    Difference
    0.3%
    Check dated 2026-04-10T21:56:06.000Z thumbnail image
  4. Check
    23 days ago
    Change Detected
    Summary
    Study Status entries were added and updated across multiple record versions, reflecting changes in the trial's recruitment and operational status.
    Difference
    0.5%
    Check dated 2026-04-03T18:50:05.000Z thumbnail image
  5. Check
    30 days ago
    Change Detected
    Difference
    0.3%
    Check dated 2026-03-27T12:43:06.000Z thumbnail image
  6. Check
    37 days ago
    Change Detected
    Summary
    New version entries (192, 191, 190, 189, 188) were added, including a Study Status update on 2026-03-19. Revision: v3.5.0 was introduced and v3.4.3 was removed.
    Difference
    0.4%
    Check dated 2026-03-20T03:43:23.000Z thumbnail image

Stay in the know with updates to Pembrolizumab and CMP-001 in Operable Melanoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab and CMP-001 in Operable Melanoma Clinical Trial page.